IDYA vs PARA · rev $15.4M vs rev $5.0M
Ideaya Biosciences Inc (IDYA) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
PARA (PARA) common stock.
Latest reported IDYA revenue for 2026-06-30 was $15.4M. Net income was -$211.0M. IDYA currently screens at market cap $2.96B.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
IDYA currently screens at market cap $2.96B. PARA currently screens at market cap $0.
Not investment advice. Open the IDYA and PARA stock pages for the full models.
Not investment advice.